Literature DB >> 31463413

Management of hepatocellular carcinoma: from bench to bedside and beyond.

Tan To Cheung1.   

Abstract

Entities:  

Year:  2019        PMID： 31463413      PMCID： PMC6691057          DOI： 10.21037/tgh.2019.07.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  7 in total

1.  Correlation between the coexpression of zinc finger and SCAN domain-containing protein 31 and transcriptional activator with PDZ-binding motif and prognosis in hepatocellular carcinoma.

Authors:  Qiang Liu; Zhengrong Shi; Xiongwei Liu; Heng Xiao
Journal:  Ann Transl Med       Date:  2020-10

2.  Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial.

Authors:  Hui-Chuan Sun; Xiao-Dong Zhu; Jian Zhou; Qiang Gao; Ying-Hong Shi; Zhen-Bing Ding; Cheng Huang; Shuang-Jian Qiu; Ning Ren; Guo-Ming Shi; Jian Sun; Qing-Hai Ye; Xiao-Wu Huang; Xin-Rong Yang; Jia Fan
Journal:  Ann Transl Med       Date:  2020-10

3.  Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma.

Authors:  Kun Ma; Jiayun Liu; Youjin Wang; Yubin Zhong; Zhenfeng Wu; Ruiying Fan; Shanfeng Guo
Journal:  J Gastrointest Oncol       Date:  2020-12

4.  Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients.

Authors:  Jinzhang Chen; Xiaoyun Hu; Qi Li; Wencong Dai; Xiao Cheng; Wei Huang; Wenxuan Yu; Mian Chen; Yabing Guo; Guosheng Yuan
Journal:  Ann Transl Med       Date:  2020-09

5.  An aberrant DNA methylation signature for predicting hepatocellular carcinoma.

Authors:  Renhua Zhang; Yafei Li; Hao Yu; Lin Liu; Changhao Zhu; Shi Zuo; Zili Chen
Journal:  Ann Transl Med       Date:  2020-12

6.  Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis.

Authors:  Pengxian Tao; Lei Gao; Haiyuan Li; Bofang Wang; Xuemei Li; Ying Zhang; Hao Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

7.  FAM172A affects cell proliferation and apoptosis not by targeting β-tubulin in HepG2 cells.

Authors:  Ai-Min Xu; Chuan-Jiang He; Zureguli Tuerxun; Abuduaini Anikezi
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.